Zinger Key Points
- Estee Lauder posts Q3 revenue of $3.940 billion, beating the analyst consensus estimate of $3.913 billion.
- Estee Lauder sees FY24 adjusted EPS of $2.14 - $2.24 against the consensus of $2.25.
- Get Monthly Picks of Market's Fastest Movers
Estee Lauder Companies Inc EL shares are trading lower after the company issued its third-quarter FY24 results.
The company reported a third-quarter sales growth of 5% year-on-year to $3.94 billion, beating the analyst consensus estimate of $3.913 billion.
Organic net sales increased 6%, primarily due to double-digit growth in Europe, the Middle East & Africa, driven by stronger sales in Asia travel retail.
Net sales in the Americas improved 3%. Sales in Europe, Middle East & Africa climbed 12%, and Asia/Pacific fell 1%.
Net sales from Skin Care grew 8%, Makeup increased 3%, Fragrance remained flat, and Hair Care decreased 3%.
Adjusted EPS of $0.97 beat the analyst consensus estimate of $0.49.
Gross profit increased 9% Y/Y to $2.83 billion, with the margin expanding 280 basis points to 71.9%.
Operating expenses remained flat at $2.3 billion, while the operating expense margin was 58.4% versus 61.2% last year.
Estee Lauder’s operating income for the quarter was $531 million, a 79% jump from $297 million last year. The operating margin was 13.5% versus 7.9% a year ago.
The company held $3.7 billion in cash and equivalents as of March-end.
The company will pay a quarterly dividend of $0.66 per share on the Company’s Class A and Class B Common Stock on June 17 to stockholders of record on May 31.
Outlook: Estee Lauder revised FY24 adjusted EPS outlook to $2.14-$2.24 (from $2.08-$2.23) against the consensus of $2.25.
EL also revised FY24 reported sales outlook to 3% decline – 2% decline (from previously expected decrease of 1% – increase of 1%).
For the fourth quarter, Estee Lauder expects adjusted EPS of $0.18-$0.28 against the consensus of $0.76. The company sees reported net sales growth of 5%-9% and organic net sales increase of 6%-10%.
Price Action: EL shares traded lower by 4.57% at $140.01 at premarket Wednesday.
Photo via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.